Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.38) by 155.26 percent. This is a 40.49 percent increase over losses of $(1.63) per share from the same period last year.
Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate of $(0.38) by 155.26 percent. This is a 40.49 percent increase over losses of $(1.63) per share from the same period last year.
Comments